NCT04710771

Brief Summary

COVID-19 is affecting the people around the world and the infected individuals' may either stay asymptomatic or present to hospitals with severe distress and life threatening symptoms. The objective of the study is to investigate role of Prone positioning and alternate nostril breathing in patients with Covid-19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable covid19

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 23, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 15, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2021

Completed
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

2 months

First QC Date

January 9, 2021

Last Update Submit

May 12, 2025

Conditions

Keywords

Covid-19General Anxiety Disorder-7Prone PositionAlternate Nostril Breathing

Outcome Measures

Primary Outcomes (3)

  • PaO2

    partial pressure of oxygen.

    Change in score before the intervention on 1st day of intervention and on 3rd day one hour after the intervention.

  • FiO2

    Fractional concentration of oxygen in inspired air \[FiO2\])

    Change in score before the intervention on 1st day of intervention and on 3rd day one hour after the intervention.

  • General Anxiety Disorder-7 Score

    general anxiety disorder-7 score ranges from 0-21, out of which 0-4 means minimal anxiety, 5-9 stands for mild anxiety, 10-14 for moderate and 15-21 for severe anxiety.

    Change in score before the intervention on 1st day of intervention and on 3rd day one hour after the intervention.

Study Arms (2)

Group-A

EXPERIMENTAL

Patient performed prone lying position for three hours.

Other: Prone Lying Position

Group-B

ACTIVE COMPARATOR

along with Prone lying position, patients also performed alternate nostril breathing for ten minutes.

Other: Prone Lying PositionOther: alternate nostril breathing

Interventions

patient lies on his/ her stomach facing floor.

Also known as: Positioning
Group-AGroup-B

patient inspires with one nostril at a time, right or left one by one and expires by mouth.

Also known as: breathing technique
Group-B

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 40-80 Gender: Both GCS score:15

You may not qualify if:

  • COPD Intubated ARDS Smoker Neurological Disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DHQ Hospital

Faisalabad, Punjab Province, 38000, Pakistan

Location

MeSH Terms

Conditions

COVID-19

Interventions

Patient Positioning

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Sahreen Anwar, PhD

    Independent Medical College, Faisalabad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2021

First Posted

January 15, 2021

Study Start

November 23, 2020

Primary Completion

January 15, 2021

Study Completion

January 29, 2021

Last Updated

May 15, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations